Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04197219
Title Pembrolizumab With Axitinib in Recurrent Endometrial Cancer
Recruitment Withdrawn
Gender female
Phase Phase II
Variant Requirements Yes
Sponsors Haider Mahdi
Age Groups: adult | senior
Covered Countries

Additional content available in CKB BOOST